$298,000
$330,000
a year
... we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies ... are rigorously advancing our mid-to late-stage clinical trials to bring ... -making. Preferred: An MBA or advanced degree is strongly preferred. Salary ...
6 days ago
$228,000
$255,000
a year
... we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies ... are rigorously advancing our mid-to late-stage clinical trials to bring ...
6 days ago